1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4

2 Introduction 5
2.1 What Is This Report About? 5
2.2 Cardiac Rhythm Management Devices Segmentation 5
2.3 Definitions of Markets Covered in the Report 6

3 Cardiac Rhythm Management Devices Market, China 8
3.1 Cardiac Rhythm Management Devices Market, China, Revenue ($m), 2015-2025 8
3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), by Segment, 2015-2025 11
3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), by Segment, 2015-2025 13
3.1.3 Pacemakers Market, China, Revenue ($m), by Segment, 2015-2025 15
3.2 Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2025 17
3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), by Segment, 2015-2025 20
3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), by Segment, 2015-2025 22
3.2.3 Pacemakers Market, China, Volume (Units), by Segment, 2015-2025 24
3.3 Cardiac Rhythm Management Devices Market, China, Average Price ($), 2015-2025 26
3.4 Cardiac Rhythm Management Devices Market, China, Distribution Share by Revenue ($m), 2017 28
3.5 Cardiac Rhythm Management Devices Market, China, Company Share by Revenue ($m), 2017 29

4 Overview of Key Companies in China, Cardiac Rhythm Management Devices Market 31
4.1 Medtronic Plc 31
4.1.1 Company Overview 31
4.2 Abbott Laboratories 31
4.2.1 Company Overview 31
4.3 Boston Scientific Corp 31
4.3.1 Company Overview 31
4.4 Biotronik AG 31
4.4.1 Company Overview 31

5 Cardiac Rhythm Management Devices Market Pipeline Products 32

6 Recent Developments 33
6.1 Corporate Communications 33
6.1.1 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 33
6.1.2 Sep 18, 2017: Concord Medical Announces Changes to the Board 33
6.1.3 Jul 24, 2017: Concord Medical Announces Changes to the Board 33
6.1.4 Jul 07, 2017: MPSC New COO Glendy Wang on Board 34
6.2 Financial Announcements 34
6.2.1 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 34
6.2.2 Aug 25, 2017: Concord Medical Reports Financial Results for the First Half of 2017 36
6.2.3 Aug 15, 2017: CareRay Exhibits At FIME 2017 37
6.2.4 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 38
6.2.5 Mar 30, 2017: MPSC Announces 2016 Annual Results 39
6.3 Other Significant Developments 40
6.3.1 Jun 29, 2017: Concord Medical Announces Construction of Proton Treatment Building of Beijing Proton Medical Center 40
6.4 Product News 41
6.4.1 Dec 18, 2017: The CFDA Approves Impulse Dynamics' Optimizer System for Treatment of Chronic Heart Failure in China 41
6.4.2 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 41
6.5 Strategy And Business Planning 42
6.5.1 Sep 21, 2017: Concord Medical Announces Construction of Shanghai Concord Cancer Hospital 42

7 Appendix 43
7.1 Research Methodology 44
7.1.1 Coverage 44
7.1.2 Secondary Research 44
7.1.3 Primary Research 45
7.1.4 Market Modeling and Forecasting 46
7.1.5 Company Share Analysis 47
7.1.6 Distribution Share Analysis 48
7.1.7 Benchmarking 48
7.2 GlobalData Consulting 48
7.3 Contact Us 49
7.4 Disclaimer 49

1.1 List of Tables
Table 1: Cardiac Rhythm Management Devices Market, China, Revenue ($m), USD Constant, 2015-2020 9
Table 2: Cardiac Rhythm Management Devices Market, China, Revenue ($m), USD Constant, 2021-2025 10
Table 3: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), USD Constant, 2015-2020 12
Table 4: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), USD Constant, 2021-2025 12
Table 5: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), USD Constant, 2015-2020 14
Table 6: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), USD Constant, 2021-2025 14
Table 7: Pacemakers Market, China, Revenue ($m), USD Constant, 2015-2020 16
Table 8: Pacemakers Market, China, Revenue ($m), USD Constant, 2021-2025 16
Table 9: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2020 18
Table 10: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2021-2025 19
Table 11: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2015-2020 21
Table 12: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2021-2025 21
Table 13: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2015-2020 23
Table 14: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2021-2025 23
Table 15: Pacemakers Market, China, Volume (Units), 2015-2020 25
Table 16: Pacemakers Market, China, Volume (Units), 2021-2025 25
Table 17: Cardiac Rhythm Management Devices Market, China, Average Price ($), 2015-2020 26
Table 18: Cardiac Rhythm Management Devices Market, China, Average Price ($), 2021-2025 27
Table 19: Cardiac Rhythm Management Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2017 28
Table 20: Cardiac Rhythm Management Devices Market, China, Company Share by Revenue ($m), USD Constant, 2017 30
Table 21: Cardiac Rhythm Management Devices Market Pipeline Products 32
Table 22: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 46

1.2 List of Figures
Figure 1: Cardiac Rhythm Management Devices Market, China, Revenue ($m), USD Constant, 2015-2025 8
Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), USD Constant, 2015-2025 11
Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), USD Constant, 2015-2025 13
Figure 4: Pacemakers Market, China, Revenue ($m), USD Constant, 2015-2025 15
Figure 5: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2025 17
Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2015-2025 20
Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2015-2025 22
Figure 8: Pacemakers Market, China, Volume (Units), 2015-2025 24
Figure 9: Cardiac Rhythm Management Devices Market, China, Company Share (%) 2017 29

Companies Mentioned
- Medtronic Plc
- Abbott Laboratories
- Boston Scientific Corp
- Biotronik AG